Lanraplenib
- Generic Name
- Lanraplenib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H25N9O
- CAS Number
- 1800046-95-0
- Unique Ingredient Identifier
- A6U64OU57E
- Background
Lanraplenib is under investigation in clinical trial NCT03285711 (Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)).
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath